Recent Finacing
Recent Raise
Pyxis Oncology develops site-specific conjugated antibody-drug conjugates and immuno-oncology antibodies targeting the tumor microenvironment and immune checkpoints to treat difficult-to-treat solid tumors and hematologic malignancies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
